Mizuho Securities changed Pediatrix Medical's rating to Underperform and set a price target of $28.

Nov 11, 2026, 7:39 AM ETOpinionRead the original at marketscreener.com

Bad for MD

Mizuho downgraded Pediatrix from Neutral to Underperform and set a $28 share target. This is a negative outside view, though the report cites no change in Pediatrix's business.

MD · Pediatrix Medical Group, Inc.

AI read · Bad for MD

The AI's read

Mizuho's change signals that it now expects Pediatrix shares to do worse than its earlier view suggested. The report gives no reason tied to sales, costs, or patient care, so this is one firm's judgment, not a reported change in the business.

Get alerts for MD

Follow Pediatrix Medical Group, Inc. (MD) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for MD

Free on the App Store and Google Play, or on the web.